01 — Financials
Financial overview
Revenue
NOK 0
Period ending 2024-12-31
Operating profit
NOK -10,800
Profit before tax
NOK -10,800
Net profit
NOK -10,800
Total assets
NOK 134,016
Equity
NOK 134,016
Latest reporting period ending 2024-12-31
02 — Signals & news
Recent activity
No signals tracked yet
Funding rounds, hiring activity, and leadership changes will appear here when detected
Set up alerts for this company
Get notified about funding, hiring, and leadership changes
03 — Get in touch
Reach STIFTELSEN NORSK FORENING FOR IMMUNOLGI OG TRANSFUSJONSMEDISINS VITENSKAPELIGE FOND
Key people
Einar Kristoffersen
Styre
Magne Børset
Styre
Bjørn Ragnar Skogen
Styre
Draft an intro emailpro
AI-generated contextual outreach
Prepare a meeting briefpro
One-page summary for your next call
Find decision-makerspro
Search by role and seniority
04 — Similar companies
Companies like STIFTELSEN NORSK FORENING FOR IMMUNOLGI OG TRANSFUSJONSMEDISINS VITENSKAPELIGE FOND
Similar company matching coming soon
We're building AI-powered matching based on industry, size, location, and business model
Discover companies in our directory
Search >100,000 Nordic companies by name, industry, or location
Get the full picture on STIFTELSEN NORSK FORENING FOR IMMUNOLGI OG TRANSFUSJONSMEDISINS VITENSKAPELIGE FOND
Financial history, alerts, outreach tools, and more. Free to use within limits.
Sign up free